Prem Venkatesan
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Pharmacology 18
- Musculoskeletal pain and rehabilitation 13
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Tuberculosis Research and Epidemiology 11
- Co-authors
- C N Paramasivan (5 shared papers)R Prabhakar (8 shared papers)Geetha Ramachandran (6 shared papers)Soumya Swaminathan (4 shared papers)Prema Gurumurthy (7 shared papers)Chandra Immanuel (4 shared papers)Ramesh Chandra Sahoo (2 shared papers)S. Rajasekaran (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Complementary Therapies in Clinical Practice (2 papers)Clinical Infectious Diseases (1 paper)Experimental Biology and Medicine (1 paper)Journal of Manipulative and Physiological Therapeutics (1 paper)
- Partner nations
- IndiaUnited Kingdom
In The Last Decade
Prem Venkatesan
46 papers receiving 972 citations
Peers
Comparison fields: 5 of 108
- Infectious Diseases 508
- Pharmacology 111
- Epidemiology 362
- Molecular Medicine 49
- Pharmacology 142
Countries citing papers authored by Prem Venkatesan
This map shows the geographic impact of Prem Venkatesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prem Venkatesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prem Venkatesan more than expected).
Fields of papers citing papers by Prem Venkatesan
This network shows the impact of papers produced by Prem Venkatesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prem Venkatesan. The network helps show where Prem Venkatesan may publish in the future.
Co-authors
The 25 scholars most cited alongside Prem Venkatesan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 118 | |
| 2 | 1986 | 90 | |
| 3 | 2004 | 82 | |
| 4 | 1996 | 72 | |
| 5 | 2005 | 65 | |
| 6 | 2001 | 59 | |
| 7 | 2009 | 57 | |
| 8 | 2012 | 53 | |
| 9 | Vitamin A levels in sputum-positive pulmonary tuberculosis patients in comparison with household contacts and healthy 'normals'. | 2004 | 32 |
| 10 | 1997 | 31 | |
| 11 | Unrecognised tuberculosis in HIV-infected patients: sputum culture is a useful tool. | 2004 | 30 |
| 12 | 2021 | 29 | |
| 13 | Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. | 2008 | 29 |
| 14 | 2010 | 28 | |
| 15 | Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report. | 1997 | 28 |
| 16 | Short-course chemotherapy in the treatment of Pott's paraplegia: report on five year follow-up. | 1997 | 28 |
| 17 | 2011 | 25 | |
| 18 | Immune response & modulation of immune response induced in the guinea-pigs by Mycobacterium avium complex (MAC) & M. fortuitum complex isolates from different sources in the south Indian BCG trial area. | 1996 | 22 |
| 19 | Bioavailability of rifampicin, isoniazid and pyrazinamide in a triple drug formulation: comparison of plasma and urine kinetics. | 1999 | 20 |
| 20 | 2012 | 19 |
About Prem Venkatesan
Prem Venkatesan is a scholar working on Pharmacology, Infectious Diseases, Surgery, Epidemiology and Psychiatry and Mental health, having authored 48 papers that have together received 1.0k indexed citations. Recurring topics across this work include Musculoskeletal pain and rehabilitation (13 papers), Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (6 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Diagnosis and treatment of tuberculosis (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Infectious Diseases and Tuberculosis (4 papers). The work is most often cited by research in Infectious Diseases (508 citations), Pharmacology (111 citations), Epidemiology (362 citations), Molecular Medicine (49 citations) and Pharmacology (142 citations). Prem Venkatesan has collaborated with scholars based in India and United Kingdom. Frequent co-authors include C N Paramasivan, R Prabhakar, Geetha Ramachandran, Soumya Swaminathan, Prema Gurumurthy, Chandra Immanuel, Ramesh Chandra Sahoo, S. Rajasekaran, Chandrasekaran Padmapriyadarsini and Prabha Adhikari. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Complementary Therapies in Clinical Practice, Clinical Infectious Diseases, Experimental Biology and Medicine and Journal of Manipulative and Physiological Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.